Image For Activity Cover
The Lead Episode 1: A Discussion of Left Bundle Branch Area Pacing Versus Biventricular Pacing as the Initial Implant Strategy for Cardiac Resynchronization Therapy
Description
Danesh Kella, MBBS, FHRS of the Mayo Clinic, Florida hosts a discussion with co-host Jason T. Jacobson, MD, FHRS of Westchester Medical Center and guests Roderick Tung, MD, FHRS of the University of Arizona – Phoenix, and Rajeev Kumar Pathak, MBBS, PhD, FHRS of Australian National University and Canberra Hospital. This episode was recorded live at Heart Rhythm 2023 in New Orleans, Louisiana.
Learning Objectives
  • Left bundle area pacing versus biventricular pacing as an initial strategy in patients requiring CRT (LBBB EF <_ 35% or RV pacing > 40%)
Target Audience
Electrophysiologists
Allied Professionals
Teaching Hospitals
Fellows
Article Authors and Podcast Contributors
Article Authors
Juan Carlos Diaz, MD; William H. Sauer MD, FHRS; Mauricio Duque, MD, FHRS; Bruce A. Koplan, MD, MPH, FHRS; Eric D. Braunstein, MD; Jorge Eduardo Marín, MD; Julian Aristizabal, MD; Cesar Daniel Niño, MD; Oriana Bastidas, MD; Juan Manuel Martinez, MD; Carolina Hoyos, MD; Carlos D. Matos, MD; Nestor LopezCabanillas, MD; Nathaniel A. Steiger, MD; Sunil Kapur, MD; Thomas M. Tadros, MD; David T. Martin, MD; Paul C. Zei, MD, PhD, FHRS; Usha B. Tedrow, MD, MS, FHRS; Jorge E. Romero MD, FHRS.

Podcast Contributors
Jason T. Jacobson, MD, FHRS of Westchester Medical Center
Danesh Kella, MBBS, FHRS of the Mayo Clinic, Florida
Rajeev Kumar Pathak, MBBS, PhD, FHRS of Australian National University and Canberra Hospital 
Roderick Tung, MD, FHRS of the University of Arizona – Phoenix
Disclosure Policy

ACE Disclosure Policy

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.

 

Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.


ACCME Definition:

*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Examples of such organizations include:

  • Advertising, marketing, or communication firms whose clients are ineligible companies
  • Bio-medical startups that have begun a governmental regulatory approval process
  • Compounding pharmacies that manufacture proprietary compounds
  • Device manufacturers or distributors
  • Diagnostic labs that sell proprietary products
  • Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
  • Manufacturers of health-related wearable products
  • Pharmaceutical companies or distributors
  • Pharmacy benefit managers
  • Reagent manufacturers or sellers

 

All relevant financial relationships have been mitigated.

Host Disclosure(s):
J. Jacobson: Honoraria/Speaking/Consulting Fee: American College of Cardiology, Zoll Medical Corporation; Research (Contracted Grants for PIs Named Investigators Only): Abbott, Phillips; Stock Ownership: Atlas 5D
D. Kella:
No relevant financial relationships with ineligible companies to disclose.

Contributor Disclosure(s):
R. Pathak: No relevant financial relationships with ineligible companies to disclose.
R. Tung: Honoraria/Speaking/Consulting Fee: Abbott, AtriCure, Biotronik, Boston Scientific, Medtronic

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
J. Glenn: No relevant financial relationships with ineligible companies to disclose. 
S. Sailor: No relevant financial relationships with ineligible companies to disclose.

Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Android App Download IOS App Download Powered By